A detailed history of Acadian Asset Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 8,142 shares of OCUL stock, worth $69,532. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,142
Holding current value
$69,532
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.45 - $9.23 $52,515 - $75,150
8,142 New
8,142 $70,000
Q1 2024

May 10, 2024

BUY
$3.85 - $10.93 $9,763 - $27,718
2,536 New
2,536 $23,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $657M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.